Health officials from CDC and the state of Texas are reeling in the wake of today's report that a second nurse at the Texas hospital that treated Ebola patient Thomas Eric Duncan has tested positive for the virus. The news came while health leaders were still trying to determine how 26-year-old nurse Nina Pham contracted Ebola while caring for the first patient diagnosed with the disease on US soil. Meanwhile, the largest nurses' union says its members report that most hospitals are not ready for an Ebola patient.
Health officials from CDC and the state of Texas are reeling in the wake of today’s report that a second nurse at the Texas hospital that treated Ebola patient Thomas Eric Duncan has tested positive for the virus. The news came while health leaders were still trying to determine how 26-year-old nurse Nina Pham contracted Ebola while caring for the first patient diagnosed with the disease on US soil.
Top public health officials grasped for answers as fears grow that most hospitals would fare no better than Texas Presbyterian if a patient exhibiting Ebola symptoms landed in their emergency room. Meanwhile, reports of suspected Ebola cases that turned out to be false alarms have started to crop up, including one from Mobile, Alabama.
In an extraordinary admission, CDC Director Thomas Frieden, MD, MPH, yesterday said that that the agency should have moved more quickly to assist Texas Presbyterian Hospital after Mr Duncan tested positive for Ebola, and said CDC would now send teams to enforce patient care protocols as soon as a diagnosis is made. Mr Duncan died on October 8, 2014, more than a week after he returned to Texas Presbyterian’s emergency department (ED) after his symptoms worsened; Texas Presbyterian officials have come under fire for sending Mr Duncan home with antibiotics when he first appeared in their ED.
“Getting it right is really, really important because the stakes are so high,” Dr Frieden said during a news conference. “We could have sent a more robust hospital infection control team and been more hands on with the hospital from Day One about how this should be managed.”
That was little comfort to the leaders of National Nurses United (NNU), who yesterday held a press conference to decry what they called sloppy conditions at Texas Presbyterian. The nurses issued updated results from a survey of 2300 members, who report that most hospitals are not prepared to treat a patient with Ebola.
“There is no standard short of optimal in protective equipment and hands-on-training that is acceptable,” said RoseAnn DeMoro, executive director of NNU, the largest US organization of nurses.
ABC News reported a union statement that Mr Duncan was left in a nonquarantined zone for hours, and a nurse supervisor faced resistance from hospital leaders after demanding that Mr Duncan be moved to an isolation unit. Additionally, Mr Duncan’s lab specimens were through the hospital’s tube system, potentially contaminating the system, the nurses said. In response, Texas Presbyterian issued a statement that numerous steps were taken to ensure patient and worker safety, including annual training and a hotline to anonymously report problems.
According to the NNU survey:
The extraordinary challenge that healthcare workers face in treating Ebola patients was highlighted further in CDC’s Mortality and Morbidity Weekly Report, which yesterday included a paper on an Ebola treatment unit within a hospital in Monrovia, Liberia. Over 2 weeks in July 2014, 5 healthcare workers contracted the virus, and 2 died, even though none of the workers reportedly had any known protocol violations that exposed them to the virus.
Around the Web
Second Health Care Worker Tests Positive for Ebola at Dallas Hospital
CDC Should Have Been More Hands On With Dallas Ebola Case, Director Says
National Conference Call for Nurses on Ebola
Cluster of Ebola Cases Among Liberian and US Healthcare Workers: MMWR
Oncology Onward: A Conversation With Dr Shereef Elnahal, Under Secretary for Health
April 20th 2023Shereef Elnahal, MD, MBA, under secretary for health at the Veterans Health Administration (VHA), sat for a conversation with our hosts Emeline Aviki, MD, MBA, Memorial Sloan Kettering Cancer Center, and Stephen Schleicher, MD, MBA, Tennessee Oncology, that covered the cancer footprint of the VHA.
Listen
Muscle-Directed Therapy Apitegromab Meets Primary End Point in Phase 3 SAPPHIRE Trial of SMA
October 17th 2024Patients aged 2-21 receiving apitegromab showed clinically meaningful motor function improvements, with a favorable safety profile consistent with long-term data, as Scholar Rock prepares for US and EU regulatory submissions in Q1 2025.
Read More